Published on 23/12/2025

Lifecycle challenges in multi market veterinary products in 2023

The global landscape for veterinary product lifecycle management is complex and multifaceted, affected by varying regulations across different regions including the US, UK, and EU. As veterinary professionals involved in regulatory affairs, quality assurance, and pharmacovigilance, understanding these challenges and finding effective solutions is crucial. This guide outlines the step-by-step process for managing the lifecycle of veterinary products across multiple markets, with a focus on compliance with the FDA’s Center for Veterinary Medicine (CVM), the European Medicines Agency (EMA), and animal health regulatory submissions globally.

Understanding the Veterinary Product Lifecycle

The lifecycle of a veterinary product encompasses several stages: discovery, development, approval, post-approval, and eventual discontinuation. Each of these stages presents unique challenges that require careful navigation. The core objective of veterinary product lifecycle management consulting services is to guide stakeholders through these complexities, ensuring compliance while optimizing product development strategies.

For veterinary products, the lifecycle generally includes:

• Discovery and Development: This initial stage involves research and development of new veterinary medicines or products. This includes target identification, formulation design, and preclinical studies.
• Regulatory Submissions: Once sufficient data is collected, the submission process to regulatory bodies begins. This stage is crucial, as it involves interaction with agencies like the FDA CVM and EMA, requiring extensive documentation and adherence to specific guidelines.
• Approval: After submission, the regulatory authority evaluates the data. Factors including safety, efficacy, and quality are scrutinized before granting approval.
• Post-Approval Monitoring: Once a product is approved, ongoing monitoring is mandated. This includes pharmacovigilance activities to track adverse effects and ensure continued compliance.
• Discontinuation: Eventually, products may be discontinued or phased out due to factors such as market competition, changes in regulation, or safety concerns.

Step 1: Conduct a Regulatory Environment Assessment

The first step in managing the lifecycle of veterinary products across multiple markets is conducting a thorough regulatory environment assessment. This involves understanding the specific requirements of each region, including the US, UK, and EU.

1. **Identify Key Regulations and Guidelines:** Each region has its own regulatory framework. In the US, the FDA CVM oversees animal drug approval and monitoring. In the EU, the EMA plays a similar role, but regulations can also vary by member state.

2. **Analyze Market Entry Requirements:** Understanding what is required to enter each market is crucial. This includes the need for clinical trials, data submission categories, language requirements, and format differences in the submission documents.

3. **Establish a Compliance Checklist:** Create a checklist that outlines the specific requirements for each market. This will serve as a foundation for ensuring compliance through each stage of the product lifecycle.

4. **Evaluate Potential Barriers:** Identify potential barriers to market entry, such as differences in scientific data requirements or varied pharmacovigilance standards.

Step 2: Develop a Strategic Regulatory Submission Plan

Once the regulatory landscape has been assessed, the next step is to develop a strategic plan for regulatory submissions. This plan should outline a clear pathway for obtaining market approval in each targeted region.

1. **Define Submission Types:** Different types of submissions may be required based on the product and its intended use. For example, filing a New Animal Drug Application (NADA) with the FDA CVM or a Marketing Authorization Application (MAA) with the EMA will have distinct requirements.

2. **Create a Timeline:** Developing a timeline for submissions is essential. This includes time estimates for research, data collection, and submission preparation, as well as for regulatory reviews.

3. **Coordinate Cross-Regional Submissions:** Leverage lessons learned from submissions in one region to enhance efficiency in another. For example, data generated for a US submission might satisfy some of the EU’s requirements, streamlining the process significantly.

4. **Engage with Regulatory Authorities:** Early engagement with regulatory bodies can provide guidance and may expedite certain review processes. Consider formal pre-submission meetings with the FDA CVM or the EMA to clarify expectations.

Step 3: Implement a Robust Quality Management System

A robust Quality Management System (QMS) is essential for ensuring compliance throughout the veterinary product lifecycle. A well-established QMS will facilitate consistency in operations and adherence to both internal and regulatory standards.

1. **Establish Standard Operating Procedures (SOPs):** Define and document SOPs for all key processes, including data collection, manufacturing, testing, and reporting. These procedures should be regularly reviewed and updated to reflect current regulations.

2. **Training and Competency:** Ensure that all personnel involved in the lifecycle management of veterinary products are adequately trained in the relevant regulations and best practices. Continuous professional development should be promoted.

3. **Data Integrity Assurance:** Implement systems to ensure data integrity. This includes minimizing data manipulation, ensuring traceability, and maintaining records that are auditable.

4. **Internal Audits and Compliance Checks:** Conduct regular internal audits to assess compliance with SOPs and regulatory requirements. Address any identified issues promptly to prevent recurrence.

Step 4: Establish Post-Market Surveillance Measures

Once a veterinary product is approved, establishing effective post-market surveillance measures is vital for ongoing compliance and product safety. This is where pharmacovigilance comes into play.

1. **Report Adverse Events:** Create a system for reporting any adverse events associated with the product. This must comply with the obligations set by regulatory authorities like the FDA CVM and EMA.

2. **Risk Management Plans:** Develop risk management plans to proactively identify potential safety issues and establish monitoring strategies. This can involve periodic safety update reports and risk-benefit assessments.

3. **Market Feedback Collection:** Implement strategies to gather feedback from veterinarians, pet owners, and other stakeholders. This data can be invaluable for identifying unforeseen issues with products.

4. **Periodic Review of Product Compliance:** Routine reviews of the product’s market performance and compliance status should be integral to post-marketing activities. Adjustments based on these reviews are crucial for sustaining product acceptance and safety assurance.

Step 5: Prepare for Field Changes and Product Lifecycle Transitioning

The final step in managing the lifecycle of veterinary products involves being prepared for changes in field conditions and planning for product transitions. Changes may arise from updated regulations, scientific advancements, or shifts in market demands.

1. **Stay Current with Regulations:** Continuous monitoring of changes in veterinary product regulations within the targeted geographical areas is essential. This includes both official releases from agencies such as the EMA and FDA as well as wider industry discussions.

2. **Evaluate Innovation and New Findings:** Regularly assess scientific literature and innovation in veterinary medicine that could affect your product. This includes evaluating new therapies or alternative treatment protocols.

3. **Plan for Product Transitioning:** As products near the end of their lifecycle, develop transition plans for phasing out products or introducing new formulations. Clear communication with stakeholders during such transitions is critical for maintaining trust and adherence.

4. **Collect and Analyze Transition Data:** When transitioning a product, ensure all changes are documented, and data is collected for regulatory review as needed. This will also provide insights into how well the transition was managed and areas for improvement.

Conclusion

Effectively managing the lifecycle of veterinary products in multiple markets requires a concerted, strategic approach. By conducting comprehensive regulatory assessments, developing strategic submission plans, implementing robust quality management practices, establishing effective post-market surveillance, and preparing for field changes, professionals in veterinary regulatory affairs can navigate the complex landscape of veterinary product lifecycle management with confidence.

In this ever-evolving environment, staying informed about updates from regulatory authorities such as the FDA CVM and the EMA is vital to ensure compliance and promote safety in veterinary medicine.